ATE110280T1 - Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. - Google Patents

Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.

Info

Publication number
ATE110280T1
ATE110280T1 AT90909466T AT90909466T ATE110280T1 AT E110280 T1 ATE110280 T1 AT E110280T1 AT 90909466 T AT90909466 T AT 90909466T AT 90909466 T AT90909466 T AT 90909466T AT E110280 T1 ATE110280 T1 AT E110280T1
Authority
AT
Austria
Prior art keywords
encouraged
active substances
effective site
substances delivered
msh4
Prior art date
Application number
AT90909466T
Other languages
English (en)
Inventor
David Peter Page-Thomas
David Roy Bard
Clive Graham Knight
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898914527A external-priority patent/GB8914527D0/en
Priority claimed from GB909007469A external-priority patent/GB9007469D0/en
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Application granted granted Critical
Publication of ATE110280T1 publication Critical patent/ATE110280T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/086—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT90909466T 1989-06-23 1990-06-22 Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. ATE110280T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898914527A GB8914527D0 (en) 1989-06-23 1989-06-23 Targetting agents
GB909007469A GB9007469D0 (en) 1990-04-03 1990-04-03 Targetting agents

Publications (1)

Publication Number Publication Date
ATE110280T1 true ATE110280T1 (de) 1994-09-15

Family

ID=26295539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90909466T ATE110280T1 (de) 1989-06-23 1990-06-22 Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.

Country Status (9)

Country Link
EP (1) EP0478631B1 (de)
JP (1) JPH04506343A (de)
AT (1) ATE110280T1 (de)
AU (1) AU636365B2 (de)
DE (1) DE69011861T2 (de)
DK (1) DK0478631T3 (de)
ES (1) ES2057572T3 (de)
NZ (1) NZ234173A (de)
WO (1) WO1991000111A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437487B1 (de) * 1988-10-04 1994-03-09 Cancer Research Campaign Technology Limited Zielmittel
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
WO1996015816A2 (en) * 1994-11-17 1996-05-30 Amgen Inc. Stable n-terminally linked dtpa:protein compositions and methods
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
US7717916B2 (en) 2007-08-16 2010-05-18 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means
US8123747B2 (en) 2007-08-16 2012-02-28 Nutek Orthopaedics, Inc. Apparatus for external fixation of a fractured distal radius with angularly adjustable pin clamping means
US8262657B2 (en) 2007-08-16 2012-09-11 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means and convergent bone pins
WO2009089066A2 (en) * 2008-01-10 2009-07-16 Stc.Unm Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
KR100999044B1 (ko) 2008-03-26 2010-12-09 한국원자력연구원 킬레이트제 접합 α-ＭＳＨ 펩타이드 유도체, 이의제조방법 및 이를 유효성분으로 함유하는 흑색종 진단 및치료용 조성물

Also Published As

Publication number Publication date
WO1991000111A1 (en) 1991-01-10
DK0478631T3 (da) 1995-04-10
AU5839190A (en) 1991-01-17
ES2057572T3 (es) 1994-10-16
AU636365B2 (en) 1993-04-29
DE69011861T2 (de) 1995-02-16
EP0478631B1 (de) 1994-08-24
NZ234173A (en) 1993-10-26
DE69011861D1 (de) 1994-09-29
JPH04506343A (ja) 1992-11-05
EP0478631A1 (de) 1992-04-08

Similar Documents

Publication Publication Date Title
DE68912302T2 (de) Härtendes material für medizinischen und dentalen gebrauch.
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
DE69717788T2 (de) Komprimierte speicherung eines patientenberichts und wiederaufbau des kompletten textes in implantierbare medizinische vorrichtungen
DE69006628T2 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
DE693928T1 (de) Aminozucker- und glykosaminoglykanzusammensetzung zur behandlung und reparatus von bindegewebe
DE3680924D1 (de) Metall-radionuklid markiertes protein fuer diagnose und therapie.
ATE106898T1 (de) Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
HUP0100507A2 (hu) Polietilén-glikol-GRF konjugátumok, eljárás azok helyspecifikus előállítására, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ATE110280T1 (de) Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.
BR9403783A (pt) Uso de uma composição cosmética
DE69531004D1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
DE68928975T2 (de) Aushärtender Werkstoff für ärztlichen und zahnärztlichen Gebrauch
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
DE194202T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutzen der oeso-gastro-duodenalen schleimhaut.
BR9007115A (pt) Novo trombolitico
IT1241681B (it) Impianto ortopedico in particolare per l'impiego per la riparazione e/o ricostruzione chirurgica di giunzioni del corpo umano
DE69822810D1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
FR2651682B1 (fr) Appareil destine a la destruction des varices des membres inferieurs chez l'homme.
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee